Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Misses Expectations By $0.04 EPS

Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Misses Expectations By $0.04 EPS

Bio-Rad Laboratories (NYSE:BIO - Get Free Report) posted its earnings results on Wednesday. The medical research company reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.25 by $0.01. Bio-Rad Laboratories had a return on equity of 4.01% and a net margin of 12.50%.

Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

Key PointsThe market didn't react positively to the diagnostics specialist's third-quarter earnings report.It beat on both the top and bottom lines, but growth rates were low.10 stocks we like better than Bio-Rad Laboratories › Healthcare diagnostics product supplier Bio-Rad Laboratories (NYSE: BIO) notched twin beats in its just-released third quarter, but that wasn't enough for a choosy stock market. Investors sold out of the company's shares …